OTCQB:IGXT – BioTuesdays

Developments

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

The U.S. Patent and Trademark Office granted a notice of allowance for an IntelGenx (TSXV:IGX; OTCQB:IGXT) patent application entitled, “Film Dosage Form with Extended Release Mucoadhesive Particles.” This film...

February 17, 2021

Developments

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

IntelGenx (TSXV:IGX; OTCQB:IGXT) filed a new provisional patent application with the U.S. Patent and Trademark Office entitled, “High Loading Oral Film Formulation.” The patent application covers the incorporation of...

February 8, 2021

Developments

IntelGenx pleased with FDA meeting on NDA resubmission for RIZAPORT VersaFilm

IntelGenx (TSXV:IGX; OTCQB:IGXT) obtained clarity on the chemistry, manufacturing and controls information required for the resubmission of its RIZAPORT VersaFilm NDA during its Type A meeting with the FDA on June 10...

June 11, 2020

Developments

IntelGenx to launch hand sanitizer business

Health Canada has cleared IntelGenx (TSXV:IGX; OTCQB:IGXT) to begin selling its liquid and gel hand sanitizer formulations, which will be produced using excess capacity at the company’s cGMP manufacturing facility in...

June 10, 2020

Tag - OTCQB:IGXT

IntelGenx receives U.S. patent allowance for DisinteQ disintegrating THC oral film

IntelGenx files provisional U.S. patent for VetaFilm high loading oral film platform

IntelGenx pleased with FDA meeting on NDA resubmission for RIZAPORT VersaFilm

IntelGenx to launch hand sanitizer business

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter